Robert Watson

Robert Watson has held a variety of roles in the corporate world since 2014. Robert began their career as a Managing Director at Altaris Capital Partners, LLC in 2014. From 2015 to 2021, they have held various board member roles at CMP Pharma, Inc., Chemical Computing Group, ReBio Technologies Limited, DuPont Sustainable Solutions, Essential Pharma, and Aleva Neurotherapeutics SA. In 2018, they became the Managing Partner at Gyrus Capital. In 2021, they were appointed as a Director Board of Directors at CORCYM.

Robert Watson attended Eton College from 1991 to 1996, where they completed their high school education. Robert then attended the University of Oxford from 1996 to 2000, where they obtained an MBiochem in Biochemistry. Robert continued their studies at the University of Oxford from 2000 to 2004, where they obtained a DPhil in Neurology.